Provided by Tiger Trade Technology Pte. Ltd.

TRANSTHERA-B

10.080
-0.090-0.88%
Volume:1.78M
Turnover:18.06M
Market Cap:4.10B
PE:-11.38
High:10.250
Open:10.170
Low:10.060
Close:10.170
52wk High:679.500
52wk Low:9.010
Shares:407.00M
HK Float Shares:312.00M
Volume Ratio:0.47
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.886
ROE:-36.78%
ROA:-20.32%
PB:4.01
PE(LYR):-11.38
PS:99.24

Loading ...

TRANSTHERA-B Announces Private Placement of 5.085 Million Shares at 18% Discount

Stock News
·
Apr 15

TransThera Sciences announces HK$290.00 million H-share placement; 5.09 million new shares priced at 18% discount

Bulletin Express
·
Apr 15

TransThera Sciences to place 5,085,000 new H shares at HK$57.03 each

Reuters
·
Apr 15

Transthera Sciences (Nanjing) Inc - Placing of 5.1 Mln Shares at HK$57.03 per Share

THOMSON REUTERS
·
Apr 15

TRANSTHERA-B Proposes Implementation of H-Share Incentive Scheme

Stock News
·
Apr 07

TRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod

Bulletin Express
·
Apr 07

TransThera proposes H-share award scheme for employee compensation

Reuters
·
Apr 07

TransThera Sciences files directors list with Hong Kong Stock Exchange

Reuters
·
Apr 01

TransThera Sciences names Feng Weibo independent director, replacing Zheng Zhelan

Reuters
·
Apr 01

TransThera proposes bylaw amendments shifting supervisory powers to board audit committee

Reuters
·
Apr 01

Transthera FY25 net loss widens 8% to RMB 296 million

Reuters
·
Apr 01

TransThera Sciences: INED Zheng Zhelan to Exit, Feng Weibo Nominated as Successor; Non-Executive Director Yi Hua Resigns

Bulletin Express
·
Mar 31

TRANSTHERA-B Proposes Appointment of Feng Weibo as Independent Non-Executive Director

Stock News
·
Mar 31

TransThera Sciences Widens Loss in 2025

MT Newswires Live
·
Mar 31

TRANSTHERA-B Reports 2025 Fiscal Year Results: Net Loss Widens to 296 Million Yuan

Stock News
·
Mar 31

BRIEF-Transthera Sciences (Nanjing) FY Loss Attributable Rmb296 Million

Reuters
·
Mar 31

Transthera Sciences (Nanjing) Inc - FY Loss Attributable RMB296 Mln

THOMSON REUTERS
·
Mar 31

TRANSTHERA-B (02617) Sets 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express
·
Mar 19

TransThera Sciences to hold board meeting on annual results and final dividend

Reuters
·
Mar 19

Tencent Holdings Reports Annual Results with 16% Profit Growth and Final Dividend

Stock News
·
Mar 19